Table 4.
Treatment‐related toxicity
| High CXI (n = 173) | Intermediate CXI (n = 36) | Low CXI (n = 57) | P | |
|---|---|---|---|---|
| Haematologic toxicity, Grade ≥3 | ||||
| Anaemia | 27 (15.6) | 11 (30.6) | 15 (26.3) | 0.038 |
| Thrombocytopenia | 37 (21.4) | 13 (36.1) | 25 (43.9) | <0.001 |
| Neutropenia | 130 (75.1) | 31 (86.1) | 46 (80.7) | 0.261 |
| Febrile neutropenia | 41 (23.7) | 16 (44.4) | 21 (36.8) | 0.022 |
| Non‐haematologic toxicity, Grade ≥3 | 54 (31.2) | 16 (44.4) | 31 (54.4) | 0.001 |
| Treatment‐related mortality | 12 (6.9) | 2 (5.6) | 8 (14.0) | 0.130 |
| Early treatment discontinuation | 18 (10.4) | 5 (13.9) | 24 (42.1) | <0.001 |
Abbreviations: CXI, cachexia index.
Data are presented as number of patients (%).